Overview

CATS Tonometer IOP Reduction Latanoprost Verses Timolol

Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
Topical Prostaglandin Analog vs Betablocker - Corneal Biomechanical Evaluation using CATS Tonometer Prism
Phase:
Phase 4
Details
Lead Sponsor:
Intuor Technologies, Inc.
Treatments:
Latanoprost
Timolol